Arcturus Therapeutics Holdings Inc (ARCT)
R&D Expense Growth
-16.30%
Quarterly · Period ending:
ARCT R&D Expense Growth
Latest reported-16.30%period ending
Latest reported-16.30%period ending
ARCT Quarterly R&D Growth (QoQ) (0.00% → -16.30%)
Latest values, visible window
High-resolution chart · PNG
ARCT r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -16.2963% | |
| -14.5081% | |
| 5.2052% | |
| -21.3462% | |
| -15.2294% | |
| -20.2992% | |
| 11.872% | |
| -33.297% | |
| 9.5123% | |
| 46.2944% | |
| -28.3043% | |
| -3.0208% | |
| 1.7385% | |
| 91.8684% | |
| -28.4096% | |
| -1.3119% | |
| -14.9333% | |
| 37.5693% | |
| -28.118% | |
| -0.6152% | |
| -8.7333% | |
| 106.0858% | |
| 37.2168% | |
| 122.7971% | |
| 0.341% | |
| -33.992% | |
| 70.0553% | |
| -2.9715% | |
| -0.751% | |
| 51.1038% | |
| 22.1214% | |
| -6.0592% | |
| 7.2063% | |
| -65.2959% | |
| 972.3324% | |
| -26.6112% | |
| -29.9515% | |
| -53.6766% | |
| -30.5156% | |
| 53.0368% | |
| 24.3902% | |
| 0.8096% | |
| 16.8945% | |
| -22.536% | |
| 2.5905% | |
| -26.8541% | |
| -43.9534% | |
| 47.9723% | |
| 7.1713% | |
| 19.9652% | |
| 122.6899% | |
| 543.9252% | |
| 328% | |
| 11.9403% | |
| -43.6975% | |
| -48.4848% | |
| 0% |